Meril Life Sciences Pvt Ltd - Product Pipeline Analysis, 2019 Update

Summary

Meril Life Sciences Pvt Ltd (Meril) is a medical device company that develops and designs clinically relevant devices. The company’s product categories include cardiovascular devices, vascular interventional devices, orthopedic devices, in-vitro diagnostics devices and endo-surgery devices. It offers coronary drug eluting stents, coronary bare metal stents, PTCA balloon dilatation catheter, bioresorbable scaffold, trans-catheters, knee systems and acetabular cup systems, IVD analyzers and reagents, surgical sutures, tissue sealants, absorbable hemostats, mesh, intra uterine devices, access devices, lab consumables, energy devices and staplers, accessories, and others. The company markets its products through direct sales, distributors and representatives offices located in India, Germany, Turkey, the US, China and Brazil. Meril is headquartered in Vapi, Gujarat, India.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Meril Life Sciences Pvt Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Meril Life Sciences Pvt Ltd Company Overview
Meril Life Sciences Pvt Ltd Company Snapshot
Meril Life Sciences Pvt Ltd Pipeline Products and Ongoing Clinical Trials Overview
Meril Life Sciences Pvt Ltd – Pipeline Analysis Overview
Meril Life Sciences Pvt Ltd - Key Facts
Meril Life Sciences Pvt Ltd - Major Products and Services
Meril Life Sciences Pvt Ltd Pipeline Products by Development Stage
Meril Life Sciences Pvt Ltd Ongoing Clinical Trials by Trial Status
Meril Life Sciences Pvt Ltd Pipeline Products Overview
Credence - Peripheral BRS
Credence - Peripheral BRS Product Overview
Credence - Peripheral BRS Clinical Trial
MeRes100
MeRes100 Product Overview
MeRes100 Clinical Trial
Myval Transcatheter Aortic Valve Replacement System - Extended Size
Myval Transcatheter Aortic Valve Replacement System - Extended Size Product Overview
Meril Life Sciences Pvt Ltd - Key Competitors
Meril Life Sciences Pvt Ltd - Key Employees
Meril Life Sciences Pvt Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Meril Life Sciences Pvt Ltd, Recent Developments
Nov 18, 2019: MyVal transcatheter heart valve reports positive trial results
Jul 11, 2019: MeRes100 BRS - the world's first thin strut sirolimus-eluting bioresorbable vascular scaffold - shows consistent long-term positive safety with consistent low mace rates and zero scaffold stent thrombosis for patients with coronary artery disease
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Meril Life Sciences Pvt Ltd Pipeline Products and Ongoing Clinical Trials Overview
Meril Life Sciences Pvt Ltd Pipeline Products by Equipment Type
Meril Life Sciences Pvt Ltd Pipeline Products by Indication
Meril Life Sciences Pvt Ltd Ongoing Clinical Trials by Trial Status
Meril Life Sciences Pvt Ltd, Key Facts
Meril Life Sciences Pvt Ltd, Major Products and Services
Meril Life Sciences Pvt Ltd Number of Pipeline Products by Development Stage
Meril Life Sciences Pvt Ltd Pipeline Products Summary by Development Stage
Meril Life Sciences Pvt Ltd Ongoing Clinical Trials by Trial Status
Meril Life Sciences Pvt Ltd Ongoing Clinical Trials Summary
Credence - Peripheral BRS - Product Status
Credence - Peripheral BRS - Product Description
Credence - Peripheral BRS - To evaluate safety and performance of CREDENCE BRS Sirolimus Eluting BioResorbable Peripheral Scaffold System in subjects with de novo native peripheral artery lesions
MeRes100 - Product Status
MeRes100 - Product Description
MeRes100 - A Multi Center Randomized Control Study of MeRes100 Sirolimus Eluting BioResorbable Vascular Scaffold System in Treatment of Coronary Artery Disease Patients: MeRes - China
MeRes100 - A Prospective, Multinational, Multicenter, Single Arm, Open Label, Pilot Clinical Study of MeRes100 Sirolimus Eluting Bioresorbable Vascular Scaffold System in the Treatment of De-novo Native Coronary Artery Lesions :MeRes-1 Extend
Myval Transcatheter Aortic Valve Replacement System - Extended Size - Product Status
Myval Transcatheter Aortic Valve Replacement System - Extended Size - Product Description
Meril Life Sciences Pvt Ltd, Key Employees
Meril Life Sciences Pvt Ltd, Other Locations
Meril Life Sciences Pvt Ltd, Subsidiaries
Glossary
List of Figures
Meril Life Sciences Pvt Ltd Pipeline Products by Equipment Type
Meril Life Sciences Pvt Ltd Pipeline Products by Development Stage
Meril Life Sciences Pvt Ltd Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook